Ann Collier, MD
Neurology · Billings, MTNPI 1487898458
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $110,987 of the $163,569 with a category attached, or 67.9%. 26 manufacturers reported payments, led by UCB, Inc. at 40.4% of the total. Reporting peaked in 2019 at $74,173 and has fallen 98.2% since, to $1,335 in 2024. Among neurology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $541.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$66K
- Livanova USA, Inc.$55K
- Neurelis, Inc.$18K
- Greenwich Biosciences, Inc.$13K
- SK Life Science, Inc.$8K
- UCB SA$2K
- plus $2K from 20 others
Across 30 payments — averaging $2942.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$88K
What the payments were for
- Consulting fees$26,60716%
- Speaking & faculty fees$110,98768%
- Travel & lodging$19,35612%
- Food & beverage$6,6194%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 132 | $66,025 |
| Livanova USA, Inc. | 65 | $55,235 |
| Neurelis, Inc. | 25 | $17,894 |
| Greenwich Biosciences, Inc. | 22 | $12,514 |
| SK Life Science, Inc. | 10 | $7,754 |
| UCB SA | 1 | $2,160 |
| Medtronic | 10 | $993 |
| AbbVie(2 entities) | 9 | $251 |
| Biohaven Pharmaceuticals, Inc. | 1 | $120 |
| Novartis | 5 | $91 |
| AstraZeneca | 1 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Tanabe Pharma America, Inc. | 1 | $50 |
| Sanofi | 2 | $48 |
| Acorda Therapeutics, Inc | 1 | $42 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Sage Therapeutics, LLC | 1 | $35 |
| Amgen(2 entities) | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| EMD Serono, Inc. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Biogen | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Briviact$55,661
- VNS Therapy$44,528
- VALTOCO$17,508
- Epidiolex$12,129
- VNS - Sentiva$9,000
- XCOPRI$7,512
- Nayzilam$1,800
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$1,125
- ACTIVA$750
- NURTEC ODT$120
How this compares
$163,569 in reported general payments places this provider in the 95th percentile of 48 neurology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobazam | 25 | $1,855 |
| Divalproex Sodium | 21 | $1,604 |
| Levetiracetam | 33 | $1,245 |
| Lamotrigine | 43 | $1,052 |
Paid to pharmacies, not to this prescriber.
Other neurology in Billings
- Kristian FrenchBillings$64K
- Sara QureshiBillings$12K
- Arturo EcheverriBillings$10K
- Daniel RodriguezBillings$2K
- Michael BradshawBillings$1K
- Jeffrey MosserBillings$464
- Scott RigginsBillings$172
- James RichardsBillings$88
- Steven ArbogastBillings$83
- Roger WilliamsBillings$37
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.